The use of normothermic liver preservation in combined liver and lung transplantation: A single-center experience.
artificial organs
clinical research
donors and donation: deceased
hepatology
liver disease
liver transplantation
lung disease
lung transplantation
organ perfusion and preservation
organ procurement and allocation
practice
pulmonology
support devices
Journal
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
ISSN: 1600-6143
Titre abrégé: Am J Transplant
Pays: United States
ID NLM: 100968638
Informations de publication
Date de publication:
09 2022
09 2022
Historique:
revised:
30
03
2022
received:
07
11
2021
accepted:
30
03
2022
pubmed:
7
4
2022
medline:
1
9
2022
entrez:
6
4
2022
Statut:
ppublish
Résumé
Combined liver and lung transplantation (CLLT) is indicated in patients with both end-stage liver and lung disease. Ex-situ normothermic machine perfusion (NMP) has been previously used for extended normothermic lung preservation in CLLT. We aim to describe our single-center experience using ex-situ NMP for extended normothermic liver preservation in CLLT. Four CLLTs were performed from 2019 to 2020 with the lung transplanted first for all patients. Median ex-situ pump time for the liver was 413 min (IQR 400-424). Over a median follow-up of 15 months (IQR 14-19), all patients were alive and doing well. Normothermic extended liver preservation is a safe method to allow prolonged cold ischemia using normothermic perfusion of the liver during CLLT.
Identifiants
pubmed: 35384271
doi: 10.1111/ajt.17053
pii: S1600-6135(22)29920-1
doi:
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Pagination
2261-2264Informations de copyright
© 2022 The American Society of Transplantation and the American Society of Transplant Surgeons.
Références
Hessheimer AJ, Riquelme F, Fundora-Suárez Y, García Pérez R, Fondevila C. Normothermic perfusion and outcomes after liver transplantation. Transplantation Reviews. 2019;33(4):200-208. 10.1016/j.trre.2019.06.001
Markmann J, Ghobrial M, Magliocca J, Demetris A, Abouljoud M. Results of the initial phase of the Portable Organ Care System (OCS™) Liver PROTECT Pivotal Trial [abstract]. Am J Transplant. 2017;17(Suppl 3):Abstract 279.
TransMedics. Liver preservation. 2014. Accessed September 2, 2021. http://www.transmedics.com/wt/page/ocsliverintromed
Freischlag KW, Messina J, Ezekian B, et al. Single-center long-term analysis of combined liver-lung transplant outcomes. Transplantation Direct. 2018;4(5):e349.
van Leeuwen OB, Brüggenwirth IMA, de Kleine RHJ, et al. Machine perfusion of donation after circulatory death liver and lungs before combined liver-lung transplantation. Transplantation Direct. 2021;7(7):e718.
Salman J, Ius F, Sommer W, et al. Lung first vs. liver first sequence for combined lung and liver transplantation [abstract]. J Heart Lung Transplant. 2016;35(4):S15. 10.1016/j.healun.2016.01.040
Siniscalchi A, Gamberini L, Laici C, et al. Post reperfusion syndrome during liver transplantation: from pathophysiology to therapy and preventive strategies. World J Gastroenterol. 2016;22(4):1551-1569.
Nasralla D, Coussios CC, Mergental H, et al. A randomized trial of normothermic preservation in liver transplantation. Nature. 2018;557(7703):50-56.
Ruiz P, Gastaca M, Bustamante FJ, et al. Favorable outcomes after liver transplantation with normothermic regional perfusion from donors after circulatory death: a single-center experience. Transplantation. 2019;103(5):938-943.
Amador A, Grande L, Martí J, et al. Ischemic pre-conditioning in deceased donor liver transplantation: a prospective randomized clinical trial. Am J Transplant. 2007;7(9):2180-2189.